论文信息 - FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease - 字舞流文

FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease

A. Schetter | Reena Philip | R. Pazdur | R. Sridhara | A. Farrell | A. Deisseroth | D. Przepiorka | Aaron J. Schetter | Donna M. Roscoe | Y. Shen | Qing Xu | E. Jen | Donna Roscoe